Improving the Diagnosis of Pneumonia in Emergency Rooms

Public Assistance-Hospitals of Marseille (AP-HM)

Status: Completed

Conditions: Pneumonia

Treatments: Other: Nasopharyngeal Swab

Study type: Interventional

Funder types: Other

Identifiers

NCT02851771

2012-43 (Other Identifier)

2012-A01589-34 (Other Identifier)

Details and patient eligibility

About

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of pneumonia caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC tests Pneumonia. This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribo Nucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribo Nucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of pneumonia after POC tests.

Enrollment: 1,364 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient admitted at hospital for pneumonia requiring, for the emergency physician, a microbiological examination with a "POC pneumonia kit."
• Patient who has freely signed the informed written consent
• Patient affiliated to a social security scheme

Exclusion criteria

• Pregnant woman, parturient or nursing
• Adult major under guardianship
• Patient deprived of liberty under court order
• Patient refusing or unable to sign the informed consent form.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,364 participants in 1 patient group

Pneumonia Patients

Experimental group

Description:

Patient admitted at hospital with pneumonia, who need a microbiological diagnosis

Treatment:

Other: Nasopharyngeal Swab